Clinical Trial Update: Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer [Phase 2]

View source ↗

Summary

This update reports Phase 2 results for cetuximab with or without weekly paclitaxel in patients with previously treated advanced urothelial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Urologic Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2017-03-31